{"title":"Modeling Catheter-Associated Bladder Mucosal Adhesion and Microtrauma Using a Human Urothelial Microtissue Model","authors":"Nazila V. Jafari, Jennifer L. Rohn","doi":"10.1002/anbr.202500254","DOIUrl":null,"url":null,"abstract":"<p>Animal models have been used to investigate urinary tract catheters, but small animals do not accurately recapitulate human bladder physiology nor support different types of catheters. Recent advances in three-dimensional models mimicking tissue microenvironments have improved our understanding of human tissue development and allowed us to model many diseases. Here, our objective was to characterise bladder urothelial mucoadhesion and microtrauma associated with intermittent catheterisation. We employed our three-dimensional Urine-tolerant Human Urothelial model (3D-UHU) to investigate two different intermittent catheter types, a polyvinylpyrrolidone (PVP)-coated catheter (PVP-CC) and a coating-free integrated amphiphilic surfactant (IAS) catheter. We showed that pressing catheters onto the models for 2 min caused compression of the 3D-UHU model in contact regions, with disruption of urothelial umbrella cells detected by immunofluorescence staining of surface markers uroplakin III, cytokeratin 20 and chondroitin sulphate, alongside occasional effacement of apical surfaces exposing intermediate layers. PVP-CC had a significantly higher number of urothelial cells adhered to its surface after catheter removal compared with IAS. Moreover, application and removal of PVP-CC caused a decrease in transepithelial electrical resistance, suggesting barrier disruption, whereas IAS did not cause a statistically different effect. However, no change in paracellular permeability rates assessed by FITC-dextran were observed in models after application of catheter pieces. Finally, compression of models induced trauma-triggered inflammatory cytokine responses. Specifically, we observed increased secretion of the pro-inflammatory cytokine IL-1β as well as the cell adhesion molecule CEACAM1 after exposure to PVP-CC compared with IAS. These data demonstrate that the 3D-UHU model holds promise as an alternative to animal models for investigating the effects of urinary catheters on the urothelium.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"6 10","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202500254","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202500254","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Animal models have been used to investigate urinary tract catheters, but small animals do not accurately recapitulate human bladder physiology nor support different types of catheters. Recent advances in three-dimensional models mimicking tissue microenvironments have improved our understanding of human tissue development and allowed us to model many diseases. Here, our objective was to characterise bladder urothelial mucoadhesion and microtrauma associated with intermittent catheterisation. We employed our three-dimensional Urine-tolerant Human Urothelial model (3D-UHU) to investigate two different intermittent catheter types, a polyvinylpyrrolidone (PVP)-coated catheter (PVP-CC) and a coating-free integrated amphiphilic surfactant (IAS) catheter. We showed that pressing catheters onto the models for 2 min caused compression of the 3D-UHU model in contact regions, with disruption of urothelial umbrella cells detected by immunofluorescence staining of surface markers uroplakin III, cytokeratin 20 and chondroitin sulphate, alongside occasional effacement of apical surfaces exposing intermediate layers. PVP-CC had a significantly higher number of urothelial cells adhered to its surface after catheter removal compared with IAS. Moreover, application and removal of PVP-CC caused a decrease in transepithelial electrical resistance, suggesting barrier disruption, whereas IAS did not cause a statistically different effect. However, no change in paracellular permeability rates assessed by FITC-dextran were observed in models after application of catheter pieces. Finally, compression of models induced trauma-triggered inflammatory cytokine responses. Specifically, we observed increased secretion of the pro-inflammatory cytokine IL-1β as well as the cell adhesion molecule CEACAM1 after exposure to PVP-CC compared with IAS. These data demonstrate that the 3D-UHU model holds promise as an alternative to animal models for investigating the effects of urinary catheters on the urothelium.
期刊介绍:
Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science.
The scope of Advanced NanoBiomed Research will cover the following key subject areas:
▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging.
▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications.
▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture.
▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs.
▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization.
▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems.
with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.